West London first-episode study of schizophrenia - Clinical correlates of duration of untreated psychosis

被引:156
作者
Barnes, TRE [1 ]
Hutton, SB [1 ]
Chapman, MJ [1 ]
Mutsatsa, S [1 ]
Puri, BK [1 ]
Joyce, EM [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Psychiat, Div Neurosci & Psychol Med, London W6 8RF, England
关键词
D O I
10.1192/bjp.177.3.207
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Studies in schizophrenia suggest that a longer initial period of untreated illness is associated with a poorer clinical outcome. Aims To determine whether, in first-episode schizophrenia. a longer duration of untreated psychosis (DUP) or of untreated illness (DUI) (DUP plus any prodrome) is associated with clinical variables that could mediate a poor prognosis. Method Clinical,social, neuropsychological and oculomotor function data on 53 patients with first-episode schizophrenia were related to the DUP and DUI. Results Comparing short and long DUP groups split around the median showed no statistically significant differences (except age); patients in the latter group tended to perform worse on an executive attentional set-shifting task, and were more likely to be unemployed, and living alone or homeless. Conclusions There was little evidence of any association between either DUP or DUI and progressive deterioration in the schizophrenic illness or the development of resistance to initial drug treatment. Social variables that augur a poor prognosis may be associated with delayed presentation of schizophrenia to psychiatric services. Declaration of interest Supported by the Wellcome Trust.
引用
收藏
页码:207 / 211
页数:5
相关论文
共 28 条
[1]   Neurocognitive and social functioning in schizophrenia [J].
Addington, J ;
Addington, D .
SCHIZOPHRENIA BULLETIN, 1999, 25 (01) :173-182
[2]  
Andreasen N C, 1990, Mod Probl Pharmacopsychiatry, V24, P73
[3]  
ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5
[4]  
BEISER M, 1993, AM J PSYCHIAT, V150, P1349
[5]   Neuropsychological impairment and psychopathology in first-episode schizophrenic patients related to the early course of illness [J].
Binder, J ;
Albus, M ;
Hubmann, W ;
Scherer, J ;
Sobizack, N ;
Franz, U ;
Mohr, F ;
Hecht, S .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1998, 248 (02) :70-77
[6]   DEFINING TREATMENT REFRACTORINESS IN SCHIZOPHRENIA [J].
BRENNER, HD ;
DENCKER, SJ ;
GOLDSTEIN, MJ ;
HUBBARD, JW ;
KEEGAN, DL ;
KRUGER, G ;
KULHANEK, F ;
LIBERMAN, RP ;
MALM, U ;
MIDHA, KK .
SCHIZOPHRENIA BULLETIN, 1990, 16 (04) :551-561
[7]   THE NORTHWICK PARK STUDY OF 1ST EPISODES OF SCHIZOPHRENIA .2. A RANDOMIZED CONTROLLED TRIAL OF PROPHYLACTIC NEUROLEPTIC TREATMENT [J].
CROW, TJ ;
MACMILLAN, JF ;
JOHNSON, AL ;
JOHNSTONE, EC .
BRITISH JOURNAL OF PSYCHIATRY, 1986, 148 :120-127
[8]   GENETIC RISK OF NEUROPSYCHOLOGICAL IMPAIRMENT IN SCHIZOPHRENIA - A STUDY OF MONOZYGOTIC TWINS DISCORDANT AND CONCORDANT FOR THE DISORDER [J].
GOLDBERG, TE ;
TORREY, EF ;
GOLD, JM ;
BIGELOW, LB ;
RAGLAND, RD ;
TAYLOR, E ;
WEINBERGER, DR .
SCHIZOPHRENIA RESEARCH, 1995, 17 (01) :77-84
[9]  
GUR RE, 1991, AM J PSYCHIAT, V148, P472
[10]   Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness [J].
Haas, GL ;
Garratt, LS ;
Sweeney, JA .
JOURNAL OF PSYCHIATRIC RESEARCH, 1998, 32 (3-4) :151-159